Vulvar and Vaginal Atrophy Therapy Market - Top Companies and Manufacturers

Companies Dominating the Vulvar And Vaginal Atrophy (Vva) Therapy Landscape

Daré Bioscience, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Almirall, S.A.
Viveve, Inc.
Lutronic Corporation
Venus Concept
ThermiGen, LLC
Alma Lasers LTD.
BTL
Fotona d.o.o.
TherapeuticsMD, Inc.

Browse Key Market Insights with Data Illustration:

Vulvar and Vaginal Atrophy (VVA) Therapy Market Size, Growth Report 2037

In the News

Dare Bioscience, Inc. has announced the initiation of the DARE-VVA1’s Phase I/II trial to evaluate a proprietary investigational formulation for the non-hormonal treatment of moderate to severe vulvar and vaginal atrophy (VVA). DARE-VVA1 is a new intravaginal tamoxifen product developed to treat vulvar and vaginal atrophy.
TherapeuticsMD, Inc. announced the approval by the U.S. Food and Drug Administration for Imvexxy 4 mcg dose. Imvexxy 4 mcg is now a commercially available drug in the United States for the treatment of dyspareunia, which is a symptom of vulvar and vaginal atrophy.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of vulvar and vaginal atrophy therapy is assessed at USD 2.9 billion.

The vulvar and vaginal atrophy therapy market size was over USD 2.46 billion in 2024 and is projected to reach USD 9.22 billion by 2037, growing at around 10.7% CAGR during the forecast period i.e., between 2025-2037. Increasing incidences of breast cancer and uterine cancer in women and the growing prevalence of UTI will boost the market growth.

North America industry is poised to hold largest revenue share by 2037, attributed to surge in the number of women suffering from pre and postmenopausal hormonal imbalances along with the growing number of vaginal cancer cases in the region.

The major players in the market are Daré Bioscience, Inc., Almirall, S.A., Viveve, Inc., Lutronic Corporation, Venus Concept, ThermiGen, LLC, Alma Lasers LTD., BTL, Fotona d.o.o., TherapeuticsMD, Inc, .

Vulvar and Vaginal Atrophy Therapy Market - Top Companies and Manufacturers

Companies Dominating the Vulvar And Vaginal Atrophy (Vva) Therapy Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the vulvar and vaginal atrophy therapy market?

What are the factors driving the vulvar and vaginal atrophy therapy landscape?

Which region held the largest vulvar and vaginal atrophy therapy industry share?

Who are the key players in the vulvar and vaginal atrophy therapy sector?